WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Performance Score
Market Cap
Revenue
EBITDA
Earnings
EPS
Revenue Growth Y/Y
Revenue Growth 5Y
Earnings Growth Y/Y
Earnings Growth 5Y
Earnings Date
WVE
WAVE LIFE SCIENCES LTD
$595.52M$113.31M-$48.98M-$57.51M-$0.543,005.10%51.04%N/AN/A2024-05-01
SLNO
SOLENO THERAPEUTICS INC
$1.22B$0.00-$36.71M-$38.99M-$2.36N/AN/AN/AN/A2024-05-07
SYRS
SYROS PHARMACEUTICALS INC
$120.10M$9.94M-$157.12M-$164.57M-$5.81-33.23%37.12%N/AN/A2024-05-08
NUVB
NUVATION BIO INC
$569.52M$0.00-$75.65M-$75.80M-$0.35N/AN/AN/AN/A2024-05-02
MACK
MERRIMACK PHARMACEUTICALS INC
$213.68M$0.00-$1.17M-$1.18M-$0.08N/AN/AN/AN/A2024-05-02
CNTB
CONNECT BIOPHARMA HOLDINGS LTD
$84.86M$0.00-$59.36M-$59.50M-$1.08N/AN/AN/AN/A
GPCR
STRUCTURE THERAPEUTICS INC
$1.69B$0.00-$88.46M-$89.62M-$2.43N/AN/AN/AN/A2024-05-09
PTIX
PROTAGENIC THERAPEUTICS INC
$5.72M$0.00-$4.86M-$5.00M-$1.15N/AN/AN/AN/A2024-05-15
BCRX
BIOCRYST PHARMACEUTICALS INC
$913.24M$331.41M-$116.34M-$226.54M-$1.1822.37%74.21%N/AN/A2024-05-01
AURA
AURA BIOSCIENCES INC
$355.94M$0.00-$73.14M-$76.41M-$1.93N/AN/AN/AN/A2024-05-06
CMPX
COMPASS THERAPEUTICS INC
$202.26M$0.00-$40.60M-$42.49M-$0.33N/AN/AN/AN/A2024-05-06
ERAS
ERASCA INC
$271.17M$0.00-$121.31M-$125.04M-$0.83N/AN/AN/AN/A2024-05-09
ABOS
ACUMEN PHARMACEUTICALS INC
$189.25M$0.00-$51.61M-$52.37M-$1.08N/AN/AN/AN/A2024-05-06
DSGN
DESIGN THERAPEUTICS INC
$209.03M$0.00-$66.29M-$66.86M-$1.19N/AN/AN/AN/A2024-05-07
INMB
INMUNE BIO INC
$150.88M$155.00k-$30.01M-$30.01M-$1.67-58.56%N/AN/AN/A2024-05-01
ORGS
ORGENESIS INC
$17.20M$530.00k-$50.83M-$55.36M$1.91-98.53%N/A223.73%N/A2024-05-08
AFMD
AFFIMED NV
$78.42M$8.99M-$114.03M-$115.15M-$7.71-79.10%-19.55%N/AN/A2024-05-21
IOVA
IOVANCE BIOTHERAPEUTICS INC
$3.16B$1.19M-$414.39M-$444.04M-$1.89N/AN/AN/AN/A2024-05-07
TNGX
TANGO THERAPEUTICS INC
$780.11M$36.53M-$95.59M-$101.74M-$1.0846.93%N/AN/AN/A2024-05-07
MTNB
MATINAS BIOPHARMA HOLDINGS INC
$40.89M$1.10M-$22.00M-$22.94M-$0.11-65.62%N/AN/AN/A2024-05-08
ONVO
ORGANOVO HOLDINGS INC
$11.04M$242.00k-$18.82M-$19.09M-$2.17-85.83%-41.45%N/AN/A2024-05-23
PRAX
PRAXIS PRECISION MEDICINES INC
$620.75M$2.45M-$122.01M-$123.28M-$18.69N/AN/AN/AN/A2024-05-09
RCUS
ARCUS BIOSCIENCES INC
$1.33B$117.00M-$285.00M-$307.00M-$4.154.46%69.54%N/AN/A2024-05-07
XNCR
XENCOR INC
$1.12B$168.34M-$108.78M-$126.09M-$2.082.28%32.90%N/AN/A2024-05-06
GERN
GERON CORP
$2.01B$237.00k-$174.78M-$184.13M-$0.32-60.23%-25.97%N/AN/A2024-05-09
SCPH
SCPHARMACEUTICALS INC
$164.41M$13.59M-$46.06M-$54.81M-$1.42N/AN/AN/AN/A2024-05-08
GNLX
GENELUX CORP
$110.95M$170.00k-$27.63M-$28.30M-$1.16-98.46%N/AN/AN/A
APM
APTORUM GROUP LTD
$29.79M$1.20M-$11.65M-$13.40M-$3.68-16.18%114.11%N/AN/A2024-04-28
ABVX
ABIVAX SA
$963.44M$5.02M-$129.52M-$160.59M-$3.735.31%N/AN/AN/A
CTMX
CYTOMX THERAPEUTICS INC
$113.10M$101.21M$9.23M-$569.00k-$0.0190.38%11.21%N/AN/A2024-05-07
BYSI
BEYONDSPRING INC
$74.52M$1.55MN/A-$27.51M-$0.7114.73%N/AN/AN/A
FBIO
FORTRESS BIOTECH INC
$33.66M$84.51M-$36.73M-$68.67M-$8.4711.58%25.75%N/AN/A2024-05-13
CDXC
CHROMADEX CORP
$277.89M$83.57M-$3.23M-$4.94M-$0.0715.99%21.50%N/AN/A2024-05-08
SYBX
SYNLOGIC INC
$21.78M$3.37M-$51.97M-$57.28M-$8.81185.68%5.99%N/AN/A2024-05-09
TSHA
TAYSHA GENE THERAPIES INC
$424.53M$15.45M-$104.02M-$111.57M-$0.96517.55%N/AN/AN/A2024-05-09
CHRS
COHERUS BIOSCIENCES INC
$233.32M$257.24M-$191.46M-$237.89M-$2.5321.89%N/AN/AN/A2024-05-06
HRTX
HERON THERAPEUTICS INC
$396.87M$127.04M-$107.16M-$110.56M-$0.8017.99%10.40%N/AN/A2024-05-09
GANX
GAIN THERAPEUTICS INC
$51.58M$55.18k-$22.10M-$22.27M-$1.71-60.62%21.77%N/AN/A2024-05-10
IBRX
IMMUNITYBIO INC
$3.55B$622.00k-$429.41M-$583.20M-$1.15159.17%67.62%N/AN/A2024-05-09
ADAP
ADAPTIMMUNE THERAPEUTICS PLC
$241.63M$60.28M-$102.70M-$113.87M-$0.54122.05%0.26%N/AN/A2024-05-06
PRQR
PROQR THERAPEUTICS NV
$161.90M$10.35M-$26.33M-$30.56M-$0.38128.23%9.83%N/AN/A2024-05-14
FTRE
FORTREA HOLDINGS INC
$3.17B$3.11B$194.70M-$3.40M-$0.040.42%N/AN/AN/A2024-05-09
OABI
OMNIAB INC
$546.98M$34.16M-$44.87M-$50.62M-$0.51-42.17%N/AN/AN/A
MGX
METAGENOMI INC
$258.18M$44.76M-$51.81M-$68.26M-$20.05160.21%N/AN/AN/A
ELAB
ELEVAI LABS INC
$9.91M$1.71M-$4.27M-$4.30M-$0.40123.50%N/AN/AN/A
AUTL
AUTOLUS THERAPEUTICS PLC
$1.20B$1.70M-$152.71M-$208.38M-$1.20-73.30%2.90%N/AN/A2024-05-01
PHAT
PHATHOM PHARMACEUTICALS INC
$524.54M$682.00k-$159.05M-$201.59M-$3.93N/AN/AN/AN/A2024-05-08
ZURA
ZURA BIO LTD
$144.30M$0.00-$60.36M-$69.24M-$2.09N/AN/AN/AN/A
GTBP
GT BIOPHARMA INC
$5.09M$0.00-$7.38M-$7.60M-$5.64N/AN/AN/AN/A2024-05-13
RNAC
CARTESIAN THERAPEUTICS INC
$96.68M$26.00M-$233.28M-$219.71M-$49.80-76.53%95.83%N/AN/A2024-05-02
REPL
REPLIMUNE GROUP INC
$395.95M$0.00-$200.44M-$209.96M-$3.16N/AN/AN/AN/A2024-05-16
VRPX
VIRPAX PHARMACEUTICALS INC
$4.31M$0.00-$15.19M-$15.19M-$12.97N/AN/AN/AN/A2024-05-14
FBRX
FORTE BIOSCIENCES INC
$26.71M$0.00-$31.47M-$31.48M-$1.00N/A-100.00%N/AN/A2024-05-13
RAPT
RAPT THERAPEUTICS INC
$276.64M$0.00-$113.25M-$116.80M-$3.05-100.00%N/AN/AN/A2024-05-09
RCKT
ROCKET PHARMACEUTICALS INC
$2.06B$0.00-$236.62M-$245.60M-$2.92N/AN/AN/AN/A2024-05-02
IVVD
INVIVYD INC
$274.21M$0.00-$196.62M-$198.64M-$1.81N/AN/AN/AN/A2024-05-10
VIGL
VIGIL NEUROSCIENCE INC
$104.01M$0.00-$80.88M-$82.64M-$2.13N/AN/AN/AN/A2024-05-09
NNVC
NANOVIRICIDES INC
$12.96M$0.00-$8.55M-$9.36M-$0.81N/AN/AN/AN/A2024-05-13
VKTX
VIKING THERAPEUTICS INC
$6.37B$0.00-$85.60M-$85.90M-$0.91N/AN/AN/AN/A2024-04-24
ALVR
ALLOVIR INC
$86.15M$0.00-$182.25M-$190.42M-$1.83N/A-100.00%N/AN/A2024-05-02
ALXO
ALX ONCOLOGY HOLDINGS INC
$782.37M$0.00-$158.40M-$160.81M-$3.74N/A-100.00%N/AN/A2024-05-09
MURA
MURAL ONCOLOGY PLC
$60.41M$0.00-$192.72M-$207.45M-$12.43N/AN/AN/AN/A
ATXI
AVENUE THERAPEUTICS INC
$5.75M$0.00-$10.38M-$10.38M-$0.98N/AN/AN/AN/A2024-05-10
LXEO
LEXEO THERAPEUTICS INC
$321.36M$0.00-$64.35M-$66.39M-$12.40-100.00%N/AN/AN/A
ADTX
ADITXT INC
$3.91M$645.18k-$27.64M-$32.70M-$108.15-30.90%N/AN/AN/A
SRZN
SURROZEN INC
$30.08M$0.00-$39.86M-$43.04M-$21.33-100.00%N/AN/AN/A2024-05-07
RLMD
RELMADA THERAPEUTICS INC
$120.70M$0.00-$98.79M-$98.79M-$3.28N/AN/AN/AN/A2024-05-09
IMVT
IMMUNOVANT INC
$4.10B$0.00-$242.72M-$243.45M-$1.83N/AN/AN/AN/A2024-05-13
GDTC
CYTOMED THERAPEUTICS LTD
$24.10M$0.00-$2.80M-$3.18M-$0.36N/AN/AN/AN/A2024-05-29
ACHL
ACHILLES THERAPEUTICS PLC
$32.17M$0.00-$64.46M-$69.67M-$1.74N/AN/AN/AN/A2024-05-08
INZY
INOZYME PHARMA INC
$278.59M$0.00-$66.51M-$71.17M-$1.37N/AN/AN/AN/A2024-05-07
IPA
IMMUNOPRECISE ANTIBODIES LTD
$33.16M$17.41M-$7.05M-$10.48M-$0.4116.75%N/AN/AN/A
APVO
APTEVO THERAPEUTICS INC
$387.83k$0.00-$16.84M-$17.41M-$62.48-100.00%-100.00%N/AN/A2024-05-09
IMRX
IMMUNEERING CORP
$52.71M$0.00-$52.71M-$53.47M-$1.88-100.00%N/AN/AN/A2024-05-07
IMUX
IMMUNIC INC
$106.12M$0.00-$93.50M-$93.61M-$2.11N/AN/AN/AN/A2024-05-09
COYA
COYA THERAPEUTICS INC
$116.34M$6.00M-$7.24M-$7.99M-$0.79N/AN/AN/AN/A2024-05-08
THTX
THERATECHNOLOGIES INC
$62.53M$57.43M-$1.41M-$13.23M-$0.41-4.06%N/AN/AN/A
INTS
INTENSITY THERAPEUTICS INC
$53.19M$0.00-$10.09M-$11.86M-$1.38N/AN/AN/AN/A
GOSS
GOSSAMER BIO INC
$176.86M$0.00-$161.92M-$179.82M-$1.18N/AN/AN/AN/A2024-05-07
ELDN
ELEDON PHARMACEUTICALS INC
$46.15M$0.00-$39.95M-$40.33M-$1.64N/AN/AN/AN/A2024-05-09
OLMA
OLEMA PHARMACEUTICALS INC
$555.23M$0.00-$94.98M-$96.66M-$2.14N/AN/AN/AN/A2024-05-07
CTNM
CONTINEUM THERAPEUTICS INC
N/A$50.00M$4.96M$3.15M$1.36N/AN/AN/AN/A
DRTS
ALPHA TAU MEDICAL LTD
$178.36M$0.00-$21.53M-$29.16M-$0.42N/AN/AN/AN/A2024-05-22
SGMT
SAGIMET BIOSCIENCES INC
$127.97M$2.00M-$27.74M-$27.88M-$2.66N/AN/AN/AN/A
QNRX
QUOIN PHARMACEUTICALS LTD
$2.62M$0.00-$8.58M-$8.69MN/AN/AN/AN/AN/A2024-05-06
NMRA
NEUMORA THERAPEUTICS INC
$1.62B$0.00-$231.63M-$235.93M-$3.63N/AN/AN/AN/A
HEPA
HEPION PHARMACEUTICALS INC
$11.00M$0.00-$49.26M-$48.93M-$12.32N/AN/AN/AN/A2024-05-13
TARA
PROTARA THERAPEUTICS INC
$30.19M$0.00-$40.08M-$40.42M-$3.57N/AN/AN/AN/A2024-05-02
EWTX
EDGEWISE THERAPEUTICS INC
$1.42B$0.00-$98.43M-$100.16M-$1.57N/AN/AN/AN/A2024-05-09
COGT
COGENT BIOSCIENCES INC
$697.26M$0.00-$188.82M-$192.41M-$2.42N/A-100.00%N/AN/A2024-05-07
MIRA
MIRA PHARMACEUTICALS INC
$12.30M$0.00-$8.53M-$11.98M-$0.64N/AN/AN/AN/A
SNTI
SENTI BIOSCIENCES INC
$14.05M$2.56M-$65.63M-$71.06M-$1.60-40.25%N/AN/AN/A2024-05-02
CRGX
CARGO THERAPEUTICS INC
$755.38M$0.00-$92.85M-$98.15M-$16.53N/AN/AN/AN/A
SRRK
SCHOLAR ROCK HOLDING CORP
$1.08B$0.00-$155.82M-$165.79M-$1.99-100.00%N/AN/AN/A2024-05-07
CARM
CARISMA THERAPEUTICS INC
$67.71M$14.92M-$80.55M-$86.88M-$2.5951.71%N/AN/AN/A2024-05-09
XERS
XERIS BIOPHARMA HOLDINGS INC
$244.39M$163.91M-$23.74M-$62.26M-$0.4548.68%132.30%N/AN/A2024-05-08
GOVX
GEOVAX LABS INC
$3.26M$0.00-$25.89M-$25.97M-$14.29-100.00%-100.00%N/AN/A2024-05-02
ATHE
ALTERITY THERAPEUTICS LTD
$11.43M$0.00N/A-$8.03M-$2.24N/AN/AN/AN/A
CRVS
CORVUS PHARMACEUTICALS INC
$68.65M$0.00-$26.88M-$27.03M-$0.56N/AN/AN/AN/A2024-05-06
RZLT
REZOLUTE INC
$135.91M$0.00-$56.28M-$56.83M-$1.10N/AN/AN/AN/A2024-05-09

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the top biotech stock with a Zen Score of 75, which is 52 points higher than the biotech industry average of 23. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -29.07% over the past year, underperforming other biotech stocks by -4 percentage points.

Incyte has an average 1 year price target of $73.92, an upside of 41.2% from Incyte's current stock price of $52.35.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Incyte, 25% have issued a Strong Buy rating, 16.67% have issued a Buy, 58.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best biotech stock with a Zen Score of 70, which is 47 points higher than the biotech industry average of 23. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -10.83% over the past year, overperforming other biotech stocks by 14 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $37.33, an upside of 26.98% from Harmony Biosciences Holdings's current stock price of $29.40.

Harmony Biosciences Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Harmony Biosciences Holdings, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 16.67% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. Voyager Therapeutics (NASDAQ:VYGR)


Voyager Therapeutics (NASDAQ:VYGR) is the third best biotech stock with a Zen Score of 66, which is 43 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Voyager Therapeutics has seen its stock lose -5.18% over the past year, overperforming other biotech stocks by 20 percentage points.

Voyager Therapeutics has an average 1 year price target of $20.50, an upside of 173.33% from Voyager Therapeutics's current stock price of $7.50.

Voyager Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Voyager Therapeutics, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Carisma Therapeutics (NASDAQ:CARM)


Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of N/A, which is N/A percentage points lower than the biotech industry average of 14.22%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Mei Pharma (NASDAQ:MEIP)


Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 53.85%, which is 40 percentage points higher than the biotech industry average of 14.22%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk A S (NYSE:NVO)


Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.12%, which is -13 percentage points lower than the biotech industry average of 14.22%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 38.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.86% in the last day, and down -6.25% over the last week. Biophytis Sa was the among the top losers in the biotechnology industry, dropping -11.04% yesterday.

Biophytis shares are trading lower after the company announced that it will change the ratio of its American Depositary Shares From 100 to 4,000.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 100, which is 85 points higher than the biotech industry average of 15. It passed 7 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -22.3% in the past year. It has overperformed other stocks in the biotech industry by 3 percentage points.

2. Voyager Therapeutics (NASDAQ:VYGR)


Voyager Therapeutics (NASDAQ:VYGR) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Voyager Therapeutics has a valuation score of 100, which is 85 points higher than the biotech industry average of 15. It passed 7 out of 7 valuation due diligence checks.

Voyager Therapeutics's stock has dropped -5.18% in the past year. It has overperformed other stocks in the biotech industry by 20 percentage points.

3. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 71 points higher than the biotech industry average of 15. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -29.07% in the past year. It has underperformed other stocks in the biotech industry by -4 percentage points.

Are biotech stocks a good buy now?

48.65% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 90.05% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 15.81x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.